Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

NCT00004688 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT00004688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1996
Completion date
July 31, 1998
Enrollment
35
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, anaplastic oligodendroglioma, glioblastoma multiforme, mixed gliomas, recurrent brain tumor